ArticleJournal of nanobiotechnology2025

Naringenin cationic lipid-modified nanoparticles mitigate MASLD progression by modulating lipid homeostasis and gut microbiota.

Lu Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.